Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial
Douglas Adkins, Jessica Ley, Jingxia Liu, Peter Oppelt
Topics & Concepts
MedicineRamucirumabPembrolizumabOncologyClinical endpointInternal medicinePhases of clinical researchHead and neck squamous-cell carcinomaResponse Evaluation Criteria in Solid TumorsHead and neck cancerClinical trialCancerImmunotherapyHead and Neck Cancer StudiesAngiogenesis and VEGF in CancerEsophageal Cancer Research and Treatment